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Abstract Most crustacean metallothioneins (MTs) contain
18 Cys residues and bind six divalent metal ions. The copper-
specific CuMT-2 (MTC) of the blue crab Callinectes sapidus
with 21 Cys residues, of which six are organized in two
uncommon Cys-Cys-Cys sequences, represents an excep-
tion. However, its metal-binding properties are unknown. By
spectroscopic and spectrometric techniques we show that all
21 Cys residues of recombinant MTC participate in the
binding of Cu(I), Zn(II), and Cd(II) ions, indicating that both
Cys triplets act as ligands. The fully metallated M8
II–MTC
(M is Zn, Cd) form possesses high- and low-affinity metal
binding sites, as evidenced by the formation of Zn6–MTC
and Cd7–MTC species from M8
II–MTC after treatment with
Chelex 100. The NMR characterization of Cd7–MTC sug-
gests the presence of a two-domain structure, each domain
containing one Cys triplet and encompassing either the three-
metal or the four-metal thiolate cluster. Whereas the metal–
Cys connectivities in the three-metal cluster located in the N-
terminal domain (residues 1–31) reveal a Cd3Cys9 cyclo-
hexane-like structure, the presence of dynamic processes in
the C-terminal domain (residues 32–64) precluded the
determination of the organization of the four-metal cluster.
Absorption and circular dichroism features accompanying
the stepwise binding of Cu(I) to MTC suggest that all 21 Cys
are involved in the binding of eight to nine Cu(I) ions (Cu8–9–
MTC). The subsequent generation of Cu12–MTC involves
structural changes consistent with a decrease in the Cu(I)
coordination number. Overall, the metal-binding properties
of MTC reported here contribute to a better understanding of
the role of Cys triplets in MTs.
Keywords Metallothionein  Metal–thiolate clusters 
Zinc  Cadmium  Copper
Introduction
Metallothioneins (MTs) comprise a wide family of ubiq-
uitous proteins with features that are exceptional from the
perspectives of both the biology and the coordination
chemistry. When compared with all other metalloproteins,
MTs are wholly unconventional because of their small size
(most of them are between 4 and 7 kDa), their high Cys
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and metal content, and the lack of tertiary structure in their
apo form (apoMT or thionein). Within the context of
coordination chemistry, MTs are also unique in that they
can form metal centers with different numbers of metals
and nature, features reflecting the influence of the poly-
peptide chain on the ligation modes of thiolate sulfur.
Another striking property of these proteins is the coexis-
tence of different coordination geometries, even for the
same metal ion. Apart from these remarkable structural
properties, the biological function of MTs is the subject of
intense research. Currently, they are considered as multi-
functional proteins, playing major roles in metal detoxifi-
cation and homeostatic trace element regulation, protection
of cells against oxidative stress, radical scavenging, and
organism growth and development [1, 2].
Two different cluster arrangements for divalent metal
ions have been structurally characterized: an M3Cys9
cluster contained in the b-domain of vertebrate, crustacean,
and echinoderm MTs, and an M4Cys11 cluster contained in
the a-domain of vertebrate and echinoderm MTs [1, 2]. A
variant of the four metal ion cluster in which two His
residues participate in metal coordination giving rise to an
M4Cys9His2 cluster has been reported for MT from cya-
nobacteria [3]. Recently, the NMR solution structure of a
plant MT has provided evidence for an unprecedented
mononuclear binding site consisting of Zn(II) tetrahedrally
coordinated by two Cys and two His residues, as found in
certain zinc-finger motifs [4].
Until quite recently, the most remarkable feature of the
primary structure of all MTs was the occurrence of Cys-
Cys, Cys-X-Cys, and Cys-X-X-Cys structural motifs,
where X stands for an amino acid residue other than Cys.
Remarkably, in the last few years, MTs containing from
one to six Cys-Cys-Cys tripeptide sequences have been
isolated from several organisms. Their genes are induced
by different metal ions and both their total length and their
Cys content vary significantly [5–12]. In the absence of 3D
structural data for these novel MTs, the participation of the
extra Cys present in the Cys triplets in metal binding
has been ruled out for human, worm, and lobster isoforms
[5–7], but has been proposed for a protozoan MT [13].
Compared with vertebrates, crustacean MTs have a
peptide chain length of 58 to 59 amino acids, with a metal
and Cys content of M6
II–MT and 18 Cys per MT, respec-
tively, instead of M7
II–MT and 20 Cys per MT [14, 15].
The alignment of crustacean MT sequences illustrates their
high sequence similarity, the only exceptions being those
of Portunus pelagicus and the copper-specific Callinectes
sapidus (Fig. 1). Remarkably, these two MTs contain two
Cys triplets and show almost identical primary structures,
which differ significantly from those of other crustacean
MTs.
Within the context of our previous work on crustacean
MTs, we now report on the recombinant synthesis and
coordinating ability of the copper-specific C. sapidus MT
(CuMT-2), denoted here as MTC. This protein is one of the
three isoforms identified in the blue crab C. sapidus and,
unlike the other two isoforms MT-1 and MT-2, is only
induced by copper ions. The metal-binding properties and
structural features reported for MT-1 and MT-2 compare
well with those of other crustacean MTs. However, since
marine crustaceans have a very dynamic copper metabo-
lism associated with the synthesis and degradation of their
respiratory protein hemocyanin, whose concentration is
dependent on the molt cycle [16], it has been hypothesized
that MTC could be involved in copper homeostasis asso-
ciated with both the synthesis and the degradation of
hemocyanin. Recently, in the analysis of the gene expres-
sion pattern of the crayfish Cherax quadricarinatus during
the molt cycle, the presence of a new MT sequence
Fig. 1 Multiple alignment analysis of a representative selection of
crustacean metallothioneins (MTs). ClustalW-aligned MT sequences
of the following organisms: Scylla serrata (Sc), Callinectes sapidus
(Cs), Carcinus maenas (Cm), Eriocheir sinensis (Es), Portunus
pelagicus (Ppe), Homarus americanus (Ha), Astacus fluviatilis (Af),
Pacifastacus leniusculus (Pl), Panulirus argus (Pa), Potamon
potamios (Ppo). The corresponding accession numbers in Swiss-Prot
are given in parentheses. Throughout this paper, Cs MT-1, Cs MT-2,
and Cs CuMT-2 are denoted as MT-1, MT-2, and MTC, respectively.
Cys residues are depicted in black and highly conserved positions in
gray
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containing Cys triplets and showing a high sequence sim-
ilarity with the copper-specific C. sapidus MTC has also
been described [17]. Therefore, the chemical character-
ization of the unconventional crustacean MTC protein
should shed light on the role of Cys triplets in this class of
metal-binding proteins.
Results and discussion
Expression and purification of recombinant Zn–MTC
The MTC complementary DNA (cDNA) was cloned into
pGEX-4T-1 expression vector, as described in ‘‘Materials
and methods.’’ The integrity and accuracy of the amplified
cDNA was confirmed by DNA sequencing. Although the
method of expression of MTs in Escherichia coli is well
established in our group [18], and has been successfully
applied in recombinant synthesis of MTs from different
organisms, it usually affords low yields [7, 19]. To increase
the average yield of 0.5 mg l-1 of bacterial culture, the
expression conditions were varied. Among those, the
addition of the corresponding metal to culture medium
after 90 min of induction, instead of the standard 30 min,
allowed us to recover about 1.5 mg l-1 of the protein.
MTC was expressed and purified as the zinc protein.
This is usually a fairly stable metalloform and, unlike
redox-active copper, is not affected by the presence of
oxygen. The presence of a single mass peak of 6,422 Da in
the electrospray ionization mass spectrometry (ESI-MS)
spectrum of the apoMTC (calculated mass 6,421.5 Da),
obtained after acidification of the Zn–MTC form, estab-
lished the correctness of the recombinant protein. This
mass includes the two additional N-terminal amino acid
residues Gly and Ser artificially introduced by the cloning
strategy. Previously, we showed that their presence does
not interfere with the metal-binding capabilities of MTs
[20].
The characterization of the recombinant Zn–MTC by
inductively coupled plasma atomic emission spectroscopy
(ICP-AES) showed a Zn-to-MTC ratio of 5.2, which differs
from the stoichiometry of the Zn–MTC species obtained by
ESI-MS. In these studies, the presence of a mixture of Znx–
MTC complexes, where x = 6–8, was obtained with Zn6–
MTC and Zn7–MTC being the main species (Table 1). As
the presence of sulfide ions was discarded on the basis of
ICP-AES analysis of acid pretreated samples [21], oxida-
tion of some Cys residues may account for the discrepancy
between the ICP-AES and ESI-MS results. However,
attempts to determine the degree of oxidation by Ellman’s
method [22] were unsuccessful owing most likely to dif-
ferences in the composition of a mixture of Znx–MTC
complexes.
Characterization of reconstituted Zn–MTC
To gain insight into the stoichiometry of Zn(II) binding to
MTC, the apoprotein was reconstituted with Zn(II) ions. The
reconstitution procedure usually affords a well-defined MT
species. However, analogously to the recombinant expres-
sion, the reconstitution of apoMTC with 8.5 mol equiv of
ZnCl2 led to a mixture of complexes Znx–MTC, x = 6–8,
whose main characteristics compare well with those
obtained from the recombinant synthesis (Tables 1, 2). The
thiolate quantification through the reaction with 2,20-
dithiopyridine (DTP) revealed that all protein thiolates are
present in their reduced state (an oxidation degree of less than
5%). The presence of a mixture of metalloforms indicates
that MTC possesses rather unusual metal-coordinating fea-
tures. Remarkably, treatment of the reconstituted sample
with the chelating resin Chelex 100 resulted essentially in a
single Zn6–MTC species (Table 2). The reversibility of this
process was ascertained by adding 2 mol equiv of Zn(II) to
Zn6–MTC, which, according to ESI-MS, reestablished the
initial Znx–MTC, x = 6–8, mixture of species (Fig. 2). This
indicates that in MTC six primary high-affinity Zn(II)
binding sites and two low-affinity sites exist. The reversible
binding of one additional divalent metal ion has also been
reported in other crustacean MTs not containing Cys triplets.
In this case, the participation of non-sulfur ligands in metal
binding has been inferred [19, 23].
Table 1 Characterization of the recombinant holo form of copper-
specific Callinectes sapidus metallothionein (MTC) obtained in media
supplemented with zinc, copper, or a mixture of both zinc and copper
Zinc-supplemented medium (300 lM ZnCl2)
ICP-AES ESI-MS
5.2 Zn/MTC Zn6–8–MTC
a
Copper-supplemented medium (500 lM CuSO4)
Homometallic species Heterometallic species
ICP-AES ESI-MS ICP-AES ESI-MS
11 Cu/MTC Cu12–14–MTC
a 6 Cu/MTC M8–13–MTC
b
2–3 Zn/MTC
Zinc- and copper-supplemented medium (300 lM ZnCl2 and 500 lM
CuSO4)
Homometallic species Heterometallic species
ICP-AES ESI-MS ICP-AES ESI-MS
11 Cu/MTC Cu11–14–MTC
a 5 Cu/MTC M8–13–MTC
b
3 Zn/MTC
ICP-AES inductively coupled plasma atomic emission spectroscopy, ESI-
MS electrospray ionization mass spectrometry
a Mixture of species with stoichiometries within the range indicated
b Within the range indicated, M8 and M12 are predominant; on the basis of
ESI-MS data it cannot be concluded whether M is Zn or Cu
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Next we addressed the question of whether the Zn6–
MTC form contains uncoordinated Cys residues. We took
advantage of the absorption band of deprotonated sulfhy-
dryl groups at 237 nm. The difference absorption spectra of
a solution of Zn6–MTC at pH 7.4 titrated with increasing
NaOH concentrations showed a band at 237 nm with a
maximum absorption at pH 11.2 (Fig. S1). The molar
absorptivity of this band divided by the determined molar
extinction coefficient per Cys (e237 = 5 9 10
3 M-1 cm-1)
revealed the presence of two unbound Cys in Zn6–MTC.
Up to now, the only canonical stoichiometry reported for
crustacean MTs in complex with divalent metal ions is
M6
II–MT, where the standard content of Cys residues is 18
[15]. However, the crustacean MTC protein contains 21
Cys residues, six of them arranged in two rather uncommon
Cys triplets. Owing to the increased number of Cys resi-
dues, the protein has the capability of forming the Znx–
MTC complexes, where x = 6–8. Interestingly, the pres-
ence of two free Cys residues in Zn6–MTC corresponds to
the number of Cys triplets present in the primary structure,
implying that one Cys of each triplet may serve as a ligand
for the binding of the last two Zn(II) ions.
The circular dichroism (CD) spectra of Zn6–MTC and
Zn6–8–MTC are shown in Fig. 2. As the aromatic amino
acids are absent from MTC, the CD features originate mainly
from the CysS–Zn(II) ligand to metal charge transfer
(LMCT) transitions. By analogy to previous CD studies of
Zn–MTs from various species, a biphasic CD profile of
Zn6–8–MTC with bands at (-)225 and (?)245 nm and a
crossover point at 239 nm originate from the excitonically
coupled transition dipole moments of the bridging thiolate
ligands in a cluster structure. Thus, in Zn6–8–MTC a cluster
structure exists. Comparison of the CD features of Zn6–MTC
and Zn6–8–MTC reveals that the binding of two additional
Zn(II) ions is accompanied by only a minor perturbation of
the original cluster structure in Zn6–MTC. A small increase
Table 2 Analysis of apoMTC after reconstitution with Zn(II) and
Cd(II)
Reconstituted Zn–MTC
ICP-AES ESI-MS
6.4 ± 0.2 Zn/MTC Zn6–8–MTC
a (Zn6–MTC)
b
Reconstituted Cd–MTC
ICP-AES ESI-MS
7.8 ± 0.8 Cd/MTC Cd8–MTC (Cd7–MTC)
c
a Mixture of species with stoichiometries within the range indicated
b Species observed after Chelex 100 treatment of the reconstituted
Zn6–8–MTC sample
c Species observed after Chelex 100 treatment of the reconstituted
Cd8–MTC sample
Fig. 2 Electrospray ionization
mass spectrometry (ESI-MS)
(a, b) and circular dichroism
(CD) (c) spectra of Zn–MTC
samples. a ApoMTC after
reconstitution with Zn(II) yields
a mixture of Zn6–8–MTC
species; b subsequent treatment
of this sample with Chelex100
affords Zn6–MTC, which
evolves into the initial Zn6–8–
MTC mixture after addition of 2
mol equiv of Zn(II); c CD
spectrum of the Zn6–8–MTC
sample (black line) compared
with that of the Zn6–MTC
species obtained after Chelex
100 treatment (red line). The
complete ESI-MS spectrum of
Zn6–MTC is shown in Fig. S6.
Theoretical and experimental
masses are detailed in Table S1
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in intensity of the CD band at 225 nm, observed upon the
binding of eight Zn(II) to MTC, is due most likely to small
changes in the peptide backbone contributions. Comparison
of the CD features of the cluster structure present in Zn6–
MTC with those reported for Zn6–MT from the crab Hom-
arus americanus [15], containing two of the M3
IICys9
clusters, shows marked differences consistent with a sub-
stantially different cluster structure in Zn6–MTC (Fig. 3).
Characterization of recombinant MTC synthesized
in copper- and copper/zinc-enriched media
MTC is specifically induced by copper in the blue crab
[11], where it plays a role in copper homeostasis [24].
These data suggest a particular adaptation of this MT to
bind copper(I) compared with divalent metal ions. To gain
insight into the binding properties of MTC toward Cu(I)
ions, the protein was expressed in copper-enriched med-
ium. Surprisingly, although all expression experiments
were performed in culture medium enriched only with
copper, either homometallic Cu–MTC or heterometallic
Cu,Zn–MTC complexes were recovered in independent
preparations (Table 1). The presence of zinc, which
accounts for the formation of the heterometallic species,
cannot be avoided because of the composition of standard
culture medium. To evaluate the role of zinc in the het-
erometallic Cu,Zn–MTC, MTC was expressed in medium
enriched with both copper and zinc. However, also in this
case either homometallic Cu–MTC or heterometallic
Cu,Zn–MTC complexes were isolated with metal-to-MTC
stoichiometries comparable to those obtained in copper-
enriched medium (Table 1). Overall, regardless of the
origin of the Cux–MTC and CuxZny–MTC forms, the ESI-
MS data allow the following generalizations: (1) the stoi-
chiometry of the various coexisting copper homometallic
species in Cux–MTC corresponds mainly to x = 12–14 and
(2) for the heterometallic CuxZny–MTC species (further
denoted as M–MTC), the predominant stoichiometries
were M8–MTC and M12–MTC. Since the Cu(I)–thiolate
bonds, unlike Zn(II)–thiolate bonds, persist at low pH, the
ESI-MS analysis of a sample containing mainly M12–MTC
species was carried out under acidic conditions. The results
showed the presence of Cu8–MTC, consistent with an
initial metal stoichiometry of Cu8Zn4–MTC. Considering
the metal-binding stoichiometries and the presence of
21 Cys in MTC, a cluster structure in both heterometallic
and homometallic forms exists. The CD spectra of both
forms are presented in Fig. 4. In these spectra, the CD
features above 250 nm originate from the CysS–Cu(I)
LMCT transitions. Comparison of the CD intensities of the
Cu8–MTC and Cu8Zn4–MTC complexes reveals a sub-
stantially higher intensity for the heterometallic form,
indicating that a mixed Cu(I),Zn(II) cluster(s) was formed.
Formation of the new Cu8Zn4–MTC species was confirmed
by comparing the CD spectrum with the CD spectra of
Cu8–MTC and Zn6–MTC, the latter also included in Fig. 4.
Within this context it may be noted that MTC isolated from
blue crab exposed to copper and cadmium simultaneously
yielded heterometallic Cu,Cd–MTC, even though the syn-
thesis of MTC is specifically induced by copper ions [25].
Similar isolation of either homometallic or heterome-
tallic MT species has already been reported and the degree
of oxygenation and culture scale have been described as
important factors for this behavior [26, 27]. In our case, we
obtained these species in multiple syntheses always per-
formed in 2-l Erlenmeyer flasks and under apparently
identical oxygenation conditions. We suggest therefore that
the high Cys content of these proteins, the ease of their
oxidation, the complexity of metal metabolism in bacteria,
and/or deficient glutathione content inside the cells may
account for these findings. Overall, consistent with the 21
Cys residues in MTC, the copper content in the homome-
tallic Cux–MTC (x = 12–14) is higher than that observed
for other crustacean MTs containing 18 Cys, where x = 10
[28]. Since the affinity of thiolates for Cu(I) normally tends
Fig. 3 Comparison of the CD spectra of the Zn6–MTC species
obtained from reconstituted Zn6–8–MTC after Chelex 100 treatment
(red line) with crustacean H. americanus Zn6–MTC (black line) [19]
Fig. 4 CD spectra of Zn6–MTC (blue line), Cu8–MTC (red line), and
Cu8Zn4–MTC (black line)
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to exceed that for Zn(II), the observed formation of het-
erometallic CuxZny–MTC species in our expression
experiments suggests that MTC may be involved in the
regulation of both metal ions.
Cu(I) binding to apoMTC
To gain deeper insight into the formation of homometallic
Cux–MTC and heterometallic CuxZny–MTC complexes,
the filling-up process of apoMTC by Cu(I) and its binding
to Zn6–8–MTC were monitored through UV, CD, and ESI-
MS measurements. In contrast to the tetrahedral tetrathio-
late coordination of Zn(II) ions, the coordination chemistry
of Cu(I) thiolates is complex. This is reflected by the
diverse coordination geometries of Cu(I) complexes, i.e.,
digonal, trigonal, and tetrahedral, the coexistence of these
binding modes in the same polynuclear complex, and the
various ligation modes of thiolate ligands [1, 29]. The only
X-ray structure reported for a Cu–MT is that of copper
thionein, Cu8–MT, from yeast. In this structure two copper
ions are coordinated digonally and the remaining six tri-
gonally through Cys ligands [30]. Although a number of
studies of Cu(I) binding to mammalian MTs have been
reported, similar studies of Cu(I) binding to crustacean
MTs are lacking. The high susceptibility of Cys ligands to
oxidation, particularly significant in nonmammalian MT
forms, has been reported as the reason for observing vari-
ability in the nuclearity of the Cu(I)–MT complexes [31].
Moreover, unlike zinc- and cadmium-containing MTs,
analysis of the ESI-MS data of Cu–MT samples is not
straightforward, mainly owing to the poor ionization of
copper-containing species [32].
The UV, CD, and ESI-MS spectra of the titration of
apoMTC with Cu(I) are presented in Fig. 5. The absorption
spectra developing with increasing Cu(I) concentrations
are characterized by a prominent shoulder at 260 nm and a
less pronounced shoulder at about 300 nm. These spectral
features increase more or less linearly in intensity with the
first 9 mol equiv of Cu(I). Moreover, no further changes in
intensity were observed with up to 12 Cu(I) (Fig. 5a). As
these absorption features originate from the CysS–Cu(I)
LMCT transitions [32–35], this behavior indicates that all
Cys ligands participate in the binding of nine Cu(I). In the
corresponding CD studies, well-resolved CD bands at
about (?)260 nm and (-)285 nm were discerned, whose
intensity increases almost linearly with the first 8 mol equiv
of Cu(I) added (Fig. 5b). Further additions of up to 12 mol
equiv of Cu(I) result in a gradual intensity decrease of
the overall CD profile. These results together with the
absorption data suggest that a well-defined cluster(s) is
formed with the first eight or nine Cu(I) and that the
binding of about the last four Cu(I) ions results in a rear-
rangement of the original cluster structure leading to the
formation of the Cu12–MTC species. The ESI-MS analyses
revealed that upon the addition of the first 2 mol equiv of
Cu(I) a Cu4–MTC complex is formed cooperatively, i.e., in
an all-or-nothing process (Fig. 5c). The formation of Cu4–
MTC may be relevant for the development of a higher
nuclearity species as already reported for other MTs
[32–35]. From this titration point on, the coexistence of
Fig. 5 ApoMTC titration with
copper: a electronic absorption
and b CD spectra of apoMTC
after addition of 0–9 mol equiv
of Cu(I) (black line) and up to
12 mol equiv of Cu(I) (red line);
c ESI-MS spectra after addition
of 2 mol equiv of Cu(I). Insets:
The family of corresponding
difference spectra obtained by
subtracting the spectrum of
apoMTC from spectra recorded
after n mol equiv of Cu(I) had
been added (n = 1–12)
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several Cu–MTC species is a common feature in all titra-
tion steps. Among the various stoichiometries observed in
ESI-MS, Cu6–MTC, Cu8–MTC, Cu10–MTC, and Cu12–
MTC appear to be predominant (data not shown). The
observation of the latter forms points to equilibrium pro-
cesses not seen in the CD and UV studies. However, as
ESI-MS is not a quantitative method and in view of the
difficulties in acquiring the ESI-MS data on Cu(I)–MT
complexes, how much these data represent the situation in
aqueous solution is not clear.
To gain insight into the heterometallic CuxZny–MTC
species formed in the recombinant synthesis, the titration of
Zn6–8–MTC with Cu(I) at pH 7 was carried out, monitoring
the spectral features of the CysS–Cu(I) LMCT bands
(Fig. 6). Although the developing absorption and CD
profiles upon the addition of Cu(I) to Zn6–8–MTC were
similar to those obtained in the Cu(I) titration of apoMTC
(Fig. 5), in the former case the maximum intensity was
reached with 12 to 13 Cu(I) and in the latter with eight to
nine Cu(I) added. This suggests that the Cu(I) binding to
the preformed structure of Zn6–8–MTC differs from that
of apoMTC. To investigate whether the heterometallic
CuxZny–MTC species obtained by displacement of Zn(II)
during the titration of Zn6–8–MTC by Cu(I) and those
obtained by recombinant biosynthesis are structurally
similar, the intensity of the corresponding CD profiles were
compared. Regardless of the metal stoichiometries in
CuxZny–MTC complexes generated in vitro, their CD
intensity was always more than 50% lower than that of the
biosynthetic Cu8Zn4–MTC (Fig. 6c). This finding indicates
that a different folding pathway for the formation of the
heterometallic species in vivo and in vitro exists. Con-
cerning the former, the prokaryotic organism E. coli is
considered as a good alternative to obtain the native MT
protein [36]. The observed structural differences imply that
the in vivo metallation process does not proceed by a prior
incorporation of Zn(II) into the nascent protein followed by
its displacement by Cu(I). This hypothesis is supported by
the observation made in crab hepatopancreas tissue
explants exposed to copper, where copper binding directly
to newly synthesized MT has been described [16].
Characterization of reconstituted Cd8–MTC
Because Zn(II) is a d10 metal with no outer-shell unpaired
electrons, it is spectroscopically silent. The coordination
environment of Zn(II) sites in proteins and their organiza-
tion are often probed with 113Cd(II), which possesses the
nuclear spin . To aid our 113Cd NMR studies, the recon-
stituted Cd–MTC form was generated and characterized by
the standard technique already applied to the Zn(II)-con-
taining MTC form (Table 2). The ICP-AES and ESI-MS
characterization of the product showed the presence of only
one species, Cd8–MTC, with a high degree of purity (pro-
tein content in reduced form of 95%). The electronic
absorption and CD spectra of Cd8–MTC are presented in
Fig. 7. The absorption spectrum is characterized by a typ-
ical metal-induced shoulder at 250 nm, observed in all Cd–
MTs and originating from CysS–Cd(II) LMCT transitions,
with the molar extinction coefficient within the range (1.0–
1.1) 9 105 M-1 cm-1. As the absorbance of a single Cd–S
bond is about 5,000 M-1 cm-1 [37], this indicates that all
21 Cys are involved in metal binding. This conclusion is
supported by the titration of apoMTC with Cd(II) (Fig. 8),
where a developed plateau with more than eight Cd(II)
added shows the same molar absorptivity. The corre-
sponding CD profile of Cd8–MTC is characterized by two
broad positive features, a band at (?)255 nm and a shoulder
at (?)235 nm. This CD profile differs substantially from
the CD profiles reported for mammalian and crustacean
Fig. 6 a Electronic absorption and b CD spectra of the Zn6–8–MTC
titration with copper at pH 7 after addition of 0–12 mol equiv of Cu(I)
(black line) and 13 mol equiv of Cu(I) (red line); c comparison of the
most chiral CD (black line) spectrum obtained in the titration [after
addition of 12 mol equiv of Cu(I)] with that of the biosynthetic
Cu8Zn4–MTC species (red line)
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Cd–MTs [18, 23, 38], where maxima at about (?)260,
(-)240, and (?)228 nm have been discerned. In these MTs,
the oppositely signed low-energy CD bands at (?)260 and
(-)240 nm have been assigned to the excitonically coupled
transition dipole moments of the bridging thiolate ligands
within the cluster structure. Thus, in Cd8–MTC the biphasic
CD profile, often used as a fingerprint of a cluster structure,
is not observed, implying unfavorable cluster geometry for
such a coupling. That a cluster structure also exists in Cd8–
MTC, albeit with an unusual cluster geometry, is evidenced
from both the stoichiometry of Cys/Cd of 2.62 in Cd8–MTC
and the position of the low-energy CD band at (?)255 nm,
diagnostic of the presence of bridging thiolate ligands.
To examine whether the fully cadmium loaded Cd8–
MTC possesses metal binding sites of different affinity, as
already observed for the Zn(II) ions, this form was treated
with Chelex 100 resin and characterized by CD (Fig. 7)
and ESI-MS (Table 2). Combination of both sets of data
shows that a new Cd7–MTC species was formed.
Remarkably, the CD envelope of Cd7–MTC shows a
biphasic profile with maxima at (?)258 and (-)235 nm,
comparable to that found in other Cd–MT species [18, 23,
38, 39], and an increased intensity when compared with
Cd8–MTC. These data indicate that the Chelex 100 treat-
ment not only causes the release of one more loosely bound
Cd(II) ion, but also leads to changes in the protein struc-
ture. Similarly to the reversible interconversion observed
between Zn6–MTC and Zn8–MTC, the addition of 1 mol
equiv of Cd(II) to Cd7–MTC yielded Cd8–MTC. To
investigate the involvement of free Cys residues in the
interconversion process between Cd8–MTC and Cd7–
MTC, the latter species was titrated with NaOH up to pH
11. Unlike the UV titration of Zn6–MTC, in this case only a
very small increase of absorbance at 237 nm was observed,
suggesting that Cd7–MTC has at most one free Cys able to
participate in the binding of the eighth Cd(II) ion (data not
shown). Comparison of the stoichiometry of the M(II)–
MTC species obtained by reconstitution of apoMTC (Zn6–8
vs. Cd8) and after Chelex 100 treatment (Zn6 vs. Cd7)
shows that although MTC possesses two binding sites with
different affinity toward both Zn(II) and Cd(II), the final
metal stoichiometries differ.
pH-titration studies were carried out to study the
stability of the cluster structure in Cd8–MTC. The dis-
placement of Cd(II) by competition with increasing con-
centrations of protons in the medium was followed by the
changes in the cadmium-induced shoulder at 250 nm in the
absorption spectra [40]. The graphical representation of the
degree of Cd(II) release with progressive acidification of
Cd8–MTC as a function of pH is indicative of a two-step
process (Fig. S2). In the first step, only one Cd(II) ion is
released within the pH range 6–4, whereas in the second
step, the remaining seven Cd(II) ions are released within
the narrow pH range between 4 and 3. Since the titration
curve did not display a pronounced two-step titration
profile, only the overall apparent binding constant was
calculated. The apparent binding constant at pH 7 of
Kapp = 3 9 10
14 M-1 obtained is similar to the apparent
binding constants reported previously for a number of other
Cd–MTs from various species using the same method [41,
42]. The calculation of the apparent stability constant is
described in ‘‘Materials and methods’’ and is based on the
following premises: (1) in Cd8–MTC all 21 Cys participate
in metal binding, yielding the molar ratio of Cys to cad-
mium of 2.62; (2) the pH midpoint value found for the
whole titration is 3.28 (Fig. S2). From the removal of the
eighth Cd(II) by Chelex100, it can be concluded that its
apparent stability constant must be lower than that of the
Cd(II)–Chelex100 complex, which was estimated to be
approximately 104.6 M-1 [39].
Binding of Cd(II) to apoMTC
To learn more about the formation of the Cd8–MTC
complex, the stepwise binding of Cd(II) to apoMTC was
monitored through UV, CD, and ESI-MS measurements.
To ensure strict oxygen-free conditions, independent
samples were prepared for each titration point (see
Fig. 7 a Electronic absorption and b CD spectra of reconstituted
Cd8–MTC (red line). Consistent with ESI-MS data (Table 2),
treatment of the latter species with Chelex 100 showed after a few
minutes the presence of a mixture of Cd7–MTC and Cd8–MTC (blue
line), which after 2–3 h evolved into Cd7–MTC exclusively (black
line)
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‘‘Materials and methods’’). The results obtained on samples
adjusted to pH 7.2 are presented in Fig. 8.
The difference absorption spectra of Cd–MTC versus
apoMTC show an incremental increase of a metal-induced
shoulder at 245 nm with the first about 4 mol equiv of
Cd(II) (De is approximately 72,000 M-1 cm-1) (Fig. 8a,
b). Further increase in absorption with the next 2 mol equiv
of Cd(II) (De is approximately 28,000 M-1 cm-1) was
accompanied by a small redshift to about 250 nm. The
binding of the last 2 mol equiv of Cd(II) is characterized by
a substantial redshift of the absorption envelope to about
262 nm and only a small intensity increase (De is
approximately 9,000 M-1 cm-1) (Fig. 8a). In the corre-
sponding CD studies (Fig. 8c), the binding of the first
4 mol equiv of Cd(II) induces an incremental increase of a
broad positive CD band centered at 240 nm with a weak
shoulder at about 250 nm, a feature resembling that seen in
the absorption spectra. Upon the addition of the fifth and
sixth Cd(II), mainly a strong CD band at (?)250 nm
develops. This CD profile is almost unaffected by the
binding of the last two Cd(II) (Fig. 8c). The ESI-MS
characterization of the metal binding process revealed at
each titration point the predominance of the Cd–MTC
complexes containing the number of Cd(II) mole equiva-
lents added. This indicates that the formation of Cd8–MTC
is a noncooperative process (Fig. S3). Taking into account
that in the absorption spectra of Cd–MTs the first CysS–
Cd(II) LMCT transition of bridging thiolates occurs at
250 nm and that the transformation of the original terminal
to bridging thiolates is accompanied by a 6-nm redshift
[43], the observed development of the absorption and CD
features suggests the following binding process. The
spectral features occurring at about 240–245 nm in both
the absorption and the CD spectra with the first four Cd(II)
would be consistent with the preferential formation of
independent Cd(II) sites. This is supported by the molar
absorptivity obtained for the initial Cd4–MTC complex,
which, when divided by the reported molar absorptivity of
a single Cd–S bond of 5,000 M-1 cm-1 [37], corresponds
to about 14 thiolate ligands. This result is in line with the
tetrathiolate metal coordination by mainly terminal thiolate
ligands. In the next binding step, the redshift and the
involvement of about six Cys in the binding of two addi-
tional Cd(II) suggest that in the Cd6–MTC complex a
cluster structure is formed, which is almost unperturbed by
the binding of the last two Cd(II) ions. In the latter case,
Fig. 8 ApoMTC titration with
Cd(II). a UV difference spectra,
Cd-MTC versus apoMTC,
obtained after addition of 1–10
mol equiv of Cd(II). The spectra
obtained after addition of 9 and
10 mol equiv of Cd(II), depicted
in red lines, are nearly
coincident. b Molar extinction
coefficient at 245 nm against
the number of mole equivalents
of Cd(II) added. c CD difference
spectra, CdMTC versus
apoMTC, after addition of 1–8
mol equiv of Cd(II).
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only about one or two Cys ligands would participate in
their binding. However, the occurrence of a dramatic red-
shift of the absorption envelope suggests that a transfor-
mation of a significant number of originally terminal
thiolates to bridging thiolates must occur. We suggest,
therefore, that the last two Cd(II) would just expand the
original cluster structure(s) in Cd6–MTC. Such behavior is
unique to MTC, as it was not seen in similar studies of MTs
from various species.
1H and 113Cd NMR studies of Cd7–MTC
Several 113Cd7–MTC samples were used to perform the
NMR experiments. In the sample preparations, their con-
centration to up to 1 mM usually produced protein aggre-
gates, precipitates, loss of metal ions, or a combination
thereof. We found that the presence of b-mercaptoethanol
(b-MeSH) was useful in avoiding the sample degradation.
However, the presence of this reducing agent in samples is
accompanied with difficulties in obtaining a full set of
NMR data required for structural studies. b-MeSH contains
protons with chemical shifts between 3.0 and 3.5 ppm,
overlapping with the b-protons of Cys residues and at
high concentrations hampers 2D homonuclear 1H NMR
experiments necessary to obtain the sequence specific
assignment of amino acids. Therefore, two sets of NMR-
acceptable samples were generated. The first, designated
MTC(1), contained a relatively low concentration of
b-MeSH (0.5–1 mM) and was used for both 1H and 113Cd
NMR experiments. The second, designated MTC(2), con-
tained a high concentration of b-MeSH (10–30 mM).
However, owing to the presence of intense proton signals
of b-MeSH at about 3.50 ppm, this sample was not suitable
for 2D 1H NMR experiments. In this case, only the 1D
113Cd and heteronuclear 1H–113Cd NMR experiments were
successful.
113Cd direct acquisition spectra for samples 113Cd7–
MTC(1) and 113Cd7–MTC(2) are shown in Fig. 9a.
MTC(1) and MTC(2) display three and seven well-resolved
113Cd signals, respectively. The chemical shift position of
these resonances occurs between 590 and 700 ppm
(Table 3) and is thus closely similar to that observed in
113Cd NMR studies of other Cd–MTs. This suggests that in
113Cd7–MTC the metal coordination by both terminal and
bridging thiolate ligands is present. The 1H–113Cd hetero-
nuclear multiple quantum correlation (HMQC) spectra
show correlations between the 113Cd metal ions and the
b-protons of Cys residues bound to them (Fig. 9b). The
chemical shift position of the 113Cd signals (A1–A3) in the
1H–113Cd HMQC spectrum of MTC(1) (Fig. 9b, red) is
identical to that observed in the 113Cd direct acquisition
spectrum, indicating that the three 113Cd ions are bound
to the polypeptide chain through Cys thiolates. In the
1H–113Cd HMQC spectrum of MTC(2) (Fig. 9b, blue),
seven clearly defined 113Cd signals are observed, of which
three (A1–A3) have the same 1H and 113Cd chemical shifts
observed in MTC(1) samples (Fig. 9b, red); the other four
resonances (B1–B4) show completely different chemical
shifts with respect to MTC(1) for both types of nuclei.
Standard 2D homonuclear 1H NMR experiments were
carried out on 113Cd7–MTC(1). Attempts to perform anal-
ogous experiments with 113Cd7–MTC(2) were unsuccessful
owing to the high concentration of b-MeSH present in
these samples (see above). The reconstituted 113Cd7–MTC
contains 66 amino acids, including 64 from the native
MTC form and two from the Gly-Ser peptide introduced at
Fig. 9 a 113Cd NMR spectrum of MTC(1) (red) and MTC(2) (blue)
samples. Signals A1–A3 (numbered according to their chemical shifts)
are observed in both samples, whereas signals B1–B4 are exclusive of
MTC(2). b Superposition of 1H–113Cd heteronuclear multiple quan-
tum correlation spectra of MTC(1) (red) and MTC(2) (blue). A1–A3
and B1–B4 113Cd signals are labeled with horizontal dashed lines.
Cross-peaks from cluster A signals are numbered in italics (see the
text). Vertical dashed lines correspond to protons belonging to Cys
bridges. Signals with lower intensity are marked with asterisks in both
spectra
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the N-terminus by the cloning strategy (see above). As four
of them are Pro residues, a total of 61 amide protons are
expected to be observed in the fingerprint region of the 2D
homonuclear 1H spectra. However, of these 61 amide
protons only 30 amide protons (49.2%) were detected in
the 2D spectra of MTC(1) (see the nuclear Overhauser
enhancement spectroscopy spectrum in Fig. S4). Therefore,
only the sequence-specific assignment of the spin systems
attached to these amide protons was carried out (Table S2).
The assignment includes, besides the attached residue Ser,
residues 1–31 of MTC, with the exception of amino acids 2
and 28, which are Pro residues. Since amide protons cor-
responding to amino acids 32–64 could not be detected, it
would appear that the first 31 amino acids of MTC(1) give
rise to the N-terminal domain of MTC (see below).
With the sequence-specific assignment at hand (Table
S2), the analysis of the 1H–113Cd HMQC spectrum of
113Cd7–MTC(1) was carried out (Fig. 9b). The analysis
provides information as to the sequence-specific connec-
tivities between the b-protons of Cys and 113Cd (reso-
nances A1–A3) and thus the organization of the three
Cd(II) sites. Attempts to perform other heteronuclear
experiments, correlating through more bonds of the Cys
side chains, were unsuccessful owing to the relatively low
concentration of the samples for these less-sensitive
experiments and mainly to a large line broadening of the
1H and 113Cd resonances. The results provide evidence for
the existence of a three-metal cluster in 113Cd7–MTC(1). A
scheme of the connectivities present in the N-terminal
cluster of MTC is shown in Fig. 10. The following
assignment was performed by comparing the 1H chemical
shifts of b-protons of the specifically assigned Cys ligands
found in the homonuclear experiments (Table S2) with
those observed in the heteronuclear experiments (Table 3).
In the heteronuclear spectra both Cd1 and Cd3 ions
give cross-peaks with a b-proton at 3.52 ppm (cross-peaks
1 and 2 in Fig. 9b), which unequivocally belongs to
Table 3 113Cd and 1H chemical shifts for MTC(1) and MTC(2) samples obtained from 113Cd direct and 1H–113Cd heteronuclear multiple
quantum correlation experiments
Cluster Cd signal Observed cross peaksa (ppm) Cys number
113Cd 1Hb
A (N-terminus) A1 (Cd1) 681.5 3.34 (17), 2.95 (18) Cys3
3.15 (19) Cys17c (bridge with A2)
3.52 (1), 2.82 (3) Cys11 (bridge with A3)
3.29 (20) Cys18c or Cys24c
A2 (Cd2) 656.8 3.15 (16) Cys17c (bridge with A1)
2.89 (15), 2.70 (14) Cys16
2.99 (5), 2.76 (7) Cys22c (bridge with A3)
2.91 (13), 2.61 (12) Cys27
A3 (Cd3) 594.7 3.14 (9) Cys5c
2.94 (10), 2.83 (11) Cys9
3.52 (2), 2.82 (4) Cys11 (bridge with A1)
2.99 (6), 2.76 (8) Cys22c (bridge with A2)
B (C-terminus) B1 619.5
B2 630.0
B3 675.6
B4 696.8
a Since only cluster A (N-terminus) has been sequentially assigned, only the cross-peaks corresponding to this cluster are shown
b The numbers in parentheses correspond to the cross-peaks cited in the text and shown in Fig. 9
c Tentative assignment (see the text)
Fig. 10 Cadmium to Cys connectivities found in the N-terminal
domain (cluster A) of MTC on the basis of NMR data. Dashed lines
indicate tentative connectivities. Cadmium numeration corresponds to
the chemical shifts (signals A1–A3 in Fig. 9)
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bridging Cys11 as the cross-peaks with the other geminal
proton at 2.82 ppm (cross-peaks 3 and 4) were also
identified (Table 3). Likewise, the Cd2 and Cd3 ions
show weak, but resolved cross-peaks at 2.99 ppm (cross-
peaks 5 and 6) that correspond to one b-proton of Cys22.
Cross-peaks between a signal at 2.76 ppm and Cd2
(cross-peak 7) confirm the coordination of this cadmium
ion to this Cys. The equivalent cross-peak with Cd3
(cross-peak 8) is probably also present, although in an
overlapping region of several Cys b-protons. Conse-
quently, Cys22 is the most probable candidate to link
these two metal ions. One well-resolved cross peak at
3.14 ppm (cross-peak 9) is observed for the Cd3 ion. This
peak can exclusively arise from Cys5 or Cys17. The
b-proton partner of either of these Cys residues does not
allow us to discriminate between these two possibilities.
The 113Cd signal A3 also provides a heteronuclear cor-
relation with proton resonances at 2.94 ppm (cross-peak
10) and 2.83 ppm (cross-peak 11), corresponding to the
b-protons of Cys9. Thus, we tentatively propose that the
Cd3 ion is bound to Cys9, Cys11 (bridging Cd1), Cys22
(bridging Cd2), and either Cys5 or Cys17. For the Cd2
ion resolved cross-peaks are observed between the 113Cd
signal A2 and protons with chemical shift at 2.61 ppm
(cross-peak 12) and 2.91 ppm (cross-peak 13), unequiv-
ocally corresponding to the b-protons of Cys27. The A2
signal of Cd2 ion is also scalar-connected to b-protons of
Cys residues with chemical shifts at 2.70 ppm (cross-peak
14) and 2.89 ppm (cross-peak 15) (Cys16). A very weak,
but resolved, cross-peak between the A2 signal and a
b-proton at 3.15 ppm (cross-peak 16) could correlate this
metal ion with either Cys 5 or Cys17. Thus, the Cd2 ion
is probably bound to Cys16, Cys22 (bridging Cd3),
Cys27, and either Cys5 or Cys17.
Cross-peaks related to the Cd1 ion are even more dif-
ficult to assign. Two cross-peaks between the 113Cd signal
A1 and the Cys b-protons at 3.34 ppm (cross-peak 17) and
2.95 ppm (cross-peak 18) correspond to Cys3. The pres-
ence of a cross-peak at 3.15 ppm (cross-peak 19) suggests
that either Cys5 or Cys17 may also be involved in the
binding of Cd1, forming then the bridge between Cd1 and
Cd2. Its geminal partner, however, does not produce any
cross-peaks. The additional A1 cross-peak at 3.29 ppm
(cross-peak 20) could correspond to either Cys18 or Cys24.
Overall, the Cd1 ion is coordinated with Cys3 and Cys11
(bridge with Cd3) and with either Cys5 or Cys17 (then, one
of these two Cys would act as a bridge with Cd2). It is
remarkable that Cys17 forms part of the first Cys triplet,
i.e., Cys16–Cys17–Cys18.
In all Cys doublets present in MTs, one of the Cys
residues is bound to a metal ion as a terminal ligand and
the other Cys bridges this metal ion to a second one
[2, 14, 15]. Since Cys16 is bound to Cd2, the previously
cited ambiguity between Cys5 or Cys17 can be resolved
in favor of the latter. In other words, we can tentatively
assign Cys17 as the bridging ligand between Cd1 and Cd2
ions. Consequently, Cys5 would be the fourth ligand of
Cd3. The inspection of available MT structures reveals
the following metal-binding properties of Cys ligands in
the structural motifs Cys-X-Cys (where X is an amino
acid different from Cys), Cys-Cys, and Cys-Cys-Cys. In
the Cys-X-Cys sequences both Cys can act as terminal
ligands, terminal and bridging ligands, but not as bridging
ligands only. In the Cys-Cys and Cys-Cys-Cys sequences
the first N-terminal Cys is always a terminal ligand and
the second one is a bridging ligand and, on the basis of
our studies, the last Cys in the Cys triplet is a terminal
ligand.
So far the 3D structure of crustacean MTs is only known
for the crab H. americanus [15] and C. sapidus MT-1 [14],
both consisting of the two M3
IICys9 clusters. The N-terminal
cluster is generally denoted as bN and the C-terminal cluster
as bC. According to the alignment of the primary sequences
(Fig. 1), we assume that the N-terminal domain in MTC
contains a similar number of amino acid residues as the bN
domain in the two already determined structures. This pro-
vides independent support for the presence of a two-domain
structure in MTC, with the N-terminal domain containing 31
amino acids. However, none of the 33 C-terminal amino
acids are observed in homonuclear experiments of MTC(1).
In this sample, prepared at a low b-MeSH concentration,
exchange phenomena are likely to occur in the second
cluster, and so neither Cd(II) ions nor amide protons are
observed in the respective experiments. Note also that
113Cd7–MTC was generated from
113Cd8–MTC through the
removal of one more labile Cd(II) by Chelex 100. However,
the rate of chemical exchange is clearly affected by the
presence of a high b-MeSH concentration since seven 113Cd
resonances were detected in the direct acquisition spectra of
113Cd7–MTC(2). These results suggest that the C-terminal
domain of MTC contains 33 amino acid residues and binds
four Cd(II) ions. Furthermore, the chemical shift position of
the corresponding four 113Cd resonances (B1–B4) is con-
sistent with their clustered organization (Fig. 9a). That in
our studies both MTC(1) and MTC(2) contained a full
complement of seven Cd(II) ions is supported by our
observation that when 113Cd7–MTC(2) samples were either
passed through a gel filtration column or treated with
Centricon devices (to remove b-MeSH), the resulting NMR
spectra (either 1H or 113Cd homonuclear, or 1H–113Cd het-
eronuclear) were essentially identical to those obtained with
113Cd7–MTC(1) samples. In other words, the removal of the
reducing agent from MTC(2) produced MTC(1). It is also
interesting that some minor 113Cd signals (marked with an
asterisk) are observed in both 113Cd direct and 1H–113Cd
HMQC experiments carried out on the MTC(2) samples
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(Fig. 9). Although their origin is not clear, they may origi-
nate either from unspecific Cd(II) binding or, more likely,
from a subset of cluster structure(s) undergoing exchange
processes.
Conclusions
The present studies on the blue crab copper specific MT
MTC with six Cys residues organized in two Cys triplets
have afforded so far unobserved metal-binding properties
in this class of proteins. We have shown that all 21 Cys
residues of MTC participate in the binding of Cu(I), Zn(II),
and Cd(II) ions, indicating that also Cys residues of both
Cys triplets act as ligands. MTC binds eight divalent Zn(II)
or Cd(II) metal ions. Both metalloforms possess high- and
low-affinity metal binding sites. Whereas the treatment of
Zn8–MTC with the complexing resin Chelex 100 removes
two Zn(II), only one Cd(II) is removed from Cd8–MTC. A
possible reason is the difference in the M(II)–S(Cys) bond
energy, which follows the order Zn(II) is lower than Cd(II).
In contrast to M8
II–MTC, the resulting metal-deficient
forms Zn6–MTC and Cd7–MTC contain two and one free
Cys, respectively. The NMR characterization of Cd7–MTC
suggests the presence of a two-domain structure, each
domain containing one Cys triplet and encompassing either
the three-metal or the four-metal thiolate cluster. The three-
metal cluster is located in the N-terminal domain (residues
1–31) and the four-metal cluster in the C-terminal domain
(residues 32–64), in which ten and 11 Cys residues are
present, respectively. The scheme of the metal–Cys con-
nectivities in the three-metal cluster of Cd7–MTC pre-
sented resembles that of cyclohexane-like clusters present
in a number of MTs. In these clusters six terminal and three
bridging Cys ligands are present. Since the metal organi-
zation determined in the three-metal cluster reveals a
Cd3Cys9 structure, the one free Cys in Cd7–MTC must be
present in the N-terminal domain, presumably Cys in the
triplet. Although the presence of a Cd3Cys9 cluster in the
N-terminal domain has been shown, the cluster organiza-
tion in the C-terminal domain could not be determined
owing mainly to chemical exchange processes.
The studies of the filling-up process of apoMTC with
Cd(II) ions suggest that the cluster structure develops with
the first six Cd(II) added, i.e., Cd6–MTC, and that its
generation is preceded by the formation of four inde-
pendent tetrathiolate Cd(II) complexes. The binding of the
last two Cd(II) ions, forming Cd8–MTC, is associated
with the transformation of a large number of originally
terminal thiolates to bridging thiolates and almost no
changes in the cluster structure of the Cd6–MTC complex.
These features are unique to MTC and point to the for-
mation of an unusual cluster structure in Cd6–MTC. On
the basis of our NMR data, we infer that in Cd6–MTC
each domain contains a Cd3–thiolate cluster. Then, the
attractive possibility accounting for the observed absorp-
tion and CD features is the scenario in which the last two
Cd(II) act as a cap generating the Cd4Cys10 and Cd4Cys11
clusters in the N- and C-terminal domains, respectively.
In this respect, the former may resemble an adamantane-
like structure and the latter a four-metal cluster found in a
number of mammalian Cd7–MTs. The characterization of
Zn–MTC shows that also in this case the formation of
Zn8–MTC is preceded by a stabler Zn6–MTC form,
whose structure is unaffected by the binding of the last
two Zn(II). Thus, the intermediate M6
II–MTC complex
with two metal–thiolate clusters forms a rigid scaffold,
owing presumably to the presence of one Cys triplet and
two Pro in each protein domain.
In the studies of the stepwise binding of Cu(I) to apo-
MTC, the absorption and CD features that developed
suggest that all 21 Cys are involved in the binding of eight
to nine Cu(I) ions and that the addition of about four Cu(I)
results in structural changes of Cu8–9–MTC and the for-
mation of Cu12–MTC. This is in a marked contrast to
similar studies of mammalian MT-1 and MT-3 (20 Cys),
where an increase in absorption occurred with up to 12
Cu(I) [34, 35]. In these studies, a digonal and trigonal Cu(I)
coordination was suggested. However, the Cu(I)-to-MTC
stoichiometry in Cu8–9–MTC is similar to that obtained
with divalent metal ions. This may suggest that in Cu8–9–
MTC the Cu(I) ions are organized in two metal–thiolate
clusters in which a tetrathiolate Cu(I) coordination exists.
Such a Cu(I) coordination has not been reported in other
Cu–MTs. In this regard, it should be noted that a direct
replacement of Zn(II) from the sites in Zn6–8–MTC by
Cu(I) did not occur, as the absorption intensity reached a
maximum with 12 Cu(I). This is due presumably to the
compactness of the Zn6–8–MTC structure and the ease for
Cu(I) ions to form stable digonal and trigonal complexes.
In summary, the metal-binding properties of copper-
specific C. sapidus MT (MTC) differ substantially from
those of other crustacean MTs. In these MTs, a total of 18
Cys are involved in binding of six divalent metal ions
[Zn(II) or Cd(II)] and up to ten Cu(I). However, in MTC
well-defined M8–MTC complexes are formed with the
divalent Zn(II) and Cd(II) and monovalent Cu(I) ions,
involving all 21 Cys. In vivo studies showed that
regardless of the metal supply (Cu or Zn and Cu) either
homometallic Cu–MTC or heterometallic Zn,Cu–MTC
were recovered in independent preparations, signifying
that MTC may play a role in the metabolism of both
metal ions. In this regard, the reversible uptake and
release of two low-affinity Zn(II) ions from the two
metal–thiolate clusters in Zn8–MTC would be consistent
with such a function.
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Materials and methods
Cloning of C. sapidus MTC cDNA
Crustacean MTC coding sequence (MTC cDNA), kindly
provided by M. Brouwer of the University of Southern
Mississippi, was cloned into pGEX-4T-1 expression vec-
tor. The coding sequence was amplified by PCR, using as a
template the MTC cDNA inserted in a pGEM plasmid. The
following oligonucleotides were used as PCR primers:
50-GAAGATCTATGCCTTGTGGAT-30 (upstream primer)
50-CGGAATTCTTACTTCATTGGG-30 (downstream
primer)
Through this reaction a BglII site was introduced
immediately before the ATG initiation codon and an EcoRI
site was introduced after the stop codon. The 30 cycles of
PCR amplification were performed with Pwo polymerase
(Roche Applied Science) under the following conditions:
94 C for 30 s, 54 C for 60 s, and 72 C for 30 s. The
PCR products were digested with BglII–EcoRI and sub-
sequently cloned into the BamHI–EcoRI sites of the pGEX-
4T-1 expression vector (GE Healthcare). This strategy
allowed us to keep the BamHI restriction site intact in the
MTC coding region. The DNA construct was confirmed by
automatic DNA sequencing. The pGEX-4T-MTC plasmids
were transformed into the E. coli protease-deficient strain
BL21 for recombinant expression. As the presence of the
rare Pro codon (CCC) could affect the amount and quality
of protein produced in E. coli, the expression in BL21
Codon Plus RP E. coli strain (Stratagene), which contains
extra copies of proL transfer RNA, was also assayed. The
sodium dodecyl sulfate polyacrylamide gel electrophoresis
analysis of protein extracts obtained from BL21 and BL21
Codon Plus RP cells, transformed by pGEX-4T-MTC, did
not show any difference in recombinant protein levels;
therefore, all the syntheses were performed in the protease-
deficient BL21 E. coli strain.
Expression and purification of the recombinant MTC
protein as different metal complexes
Medium-scale cultures for analytical purposes (2 l) were
grown in Erlenmeyer flasks, whereas large-scale cultures
(50 l) for NMR studies were performed in a Biostat UD50
pilot-scale bioreactor. In both cases, the transformed E. coli
BL21 cells were grown in Luria–Bertani medium supple-
mented with 100 lg ml-1 ampicillin and one of the fol-
lowing metal salt supplements: 300 lM ZnCl2 for zinc-
enriched medium, 500 lM CuSO4 for copper-enriched
medium, and 300 lM ZnCl2 plus 500 lM CuSO4 for zinc-
and copper-enriched medium. The cultures were induced
with isopropyl 1-thio-b-D-galactopyranoside at a final
concentration of 100 lM. Purification of metal–MTC
complexes was performed as described for mouse MT-1
[20]. After the gel filtration chromatography, samples were
pooled and stored at -80 C under an argon atmosphere
until further analysis.
Preparation and characterization of apoMTC
Vasˇa´k’s method [44] provides a useful strategy to obtain
fully loaded MTs via the previous purification of the cor-
responding apo form. Minor modifications to this method
enabled us to recover apoMTC with a high degree of purity.
Solutions containing 1–10 mg of recombinant Zn–MTC, in
20 mM tris(hydroxymethyl)aminomethane (Tris)–HCl (pH
7.5–8), were incubated for 45 min with 20 mol equiv of
dithiothreitol per Cys residue and 4 M guanidine hydro-
chloride, under argon bubbling. Acidification of the solution
to pH 1–1.5 was achieved by the addition of 6 M HCl.
Centriprep YM-3 concentrators (Amicon) were used to
concentrate the sample to 1–2 ml. Gel filtration through a
Sephadex G-10 column (1.5 cm 9 42 cm) equilibrated
with 10 mM HCl and elution with the same solution
(1 ml min-1) allowed removal of the Zn(II) ions released
from Zn–MTC at low pH. The eluate was collected in 1-ml
fractions and monitored for absorbance at 220 nm. The
fractions corresponding to apoMTC were pooled. The
protein concentration and the total metal content were
determined by ICP-AES analysis. The apoMTC sample was
kept at -80 C until further use. ICP-AES and ESI-MS data
indicated the absence of metals, and DTP reaction showed
an oxidation degree lower than 5%. The CD (no bands at a
wavelength higher than 220 nm) and UV (no bands at a
wavelength higher than 240 nm) features were fully con-
sistent with those of metal-free MTC.
The average acidity constant of the Cys residues in
apoMTC and the molar extinction coefficient for a depro-
tonated Cys residue were calculated from the spectropho-
tometric titration with NaOH (Fig. S5) using a reported
procedure [42]. Both values, pKa = 9.0 and e237 = 5 9
103 M-1 cm-1 per Cys, compare well with those reported
for mammalian MTs [40].
Reconstitution of apoMTC with Zn(II) or Cd(II)
Fully loaded Zn(II) or Cd(II) MTC was prepared by
reconstitution following a slightly modified Vasˇa´k’s
method [44]. The solutions used were rendered oxygen-
free by three freeze–pump–thaw cycles on a vacuum line
and all sample preparation steps were performed in an
argon-purged glove box. Both fully loaded Zn–MTC and
Cd–MTC forms were obtained by the mixing of 8.5 mol
equiv of ZnCl2 or CdCl2, respectively, with apoMTC in
10 mM HCl. The solution mixture was then adjusted to pH
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7 with 1 M Tris base and incubated overnight. Finally, a
gel filtration chromatography was performed in an A¨KTA
purifier (GE Healthcare) to remove the excess of metal
ions. The Superdex-75 HR column was equilibrated with
10 mM Tris–HCl, pH 7.2 and run at 0.5 ml min-1.
Analytical and spectroscopic techniques
The sulfur, zinc, cadmium and copper content of apoMTC
and holoMTC samples was analyzed by means of ICP-AES
using a Polyscan 61E (Thermo Jarrell Ash) spectrometer,
measuring sulfur at 182.040 nm, zinc at 213.856 nm,
cadmium at 228.802 nm, and copper at 324.803 nm. The
sample preparation was performed as already described
[45]. To evaluate possible traces of labile sulfide ions in
recombinant metal–MTC complexes, the corresponding
samples were incubated in 1 M HCl at 65 C for 5 min
prior to measurements by ICP-AES [21]. For all samples,
the protein concentration was calculated from the sulfur
content determined by ICP-AES assuming that all sulfur
atoms were contributed by the MTC peptide, i.e., 23 sulfur
atoms per mole of MTC (two Met and 21 Cys residues).
The percentage of thiol groups in reduced form over the
total sulfur content in the samples of apoMTC and recon-
stituted MTC was determined through the reaction of MTC
with DTP in 0.2 M sodium acetate/1 mM EDTA (pH 4),
which was followed spectroscopically using e343 =
7,600 M-1 cm-1 [38].
A JASCO spectropolarimeter (model J-715) interfaced to
a computer (J700 software) was used for CD measurements.
Electronic absorption measurements were performed with
an HP-8453 diode-array UV–vis spectrophotometer. All
spectra were recorded from samples in 1-cm capped quartz
cuvettes, corrected for the dilution effects and processed
using the GRAMS 32 program.
The molecular mass of holoMTC samples was determined
by ESI-MS using an Ultima Micromass quadrupole time-of-
flight instrument, controlled by MassLynx software and
calibrated with NaI (0.2 g of NaI dissolved in 100 ml of a 1:1
H2O/2-propanol mixture). Samples of 20-ll volume were
injected at 40 ll min-1 under the following conditions:
source temperature, 100–150 C; desolvation temperature,
150–250 C; capillary counter electrode voltage, 3.0 kV;
cone potential, 80 V. Spectra were collected throughout an
m/z range from 950 to 2,000 at a rate of 2 s per scan with an
interscan delay of 0.1 s. The liquid carrier was a 10:90
mixture of acetonitrile and 5 mM ammonium acetate, pH 7.
The same ESI-MS equipment was used to assess the
correctness of recombinant Zn6–8–MTC. This was ascer-
tained by determining the molecular mass of the corre-
sponding apoMTC form, which was obtained by using a
liquid carrier consisting of a 50:50 mixture of acetonitrile
and ammonium formate/ammonia at pH 2.5. Also, the
source temperature was decreased to 100 C and the
desolvation temperature to 150 C. The other experimental
conditions were the same as described above. In all cases,
molecular masses were theoretically calculated as previ-
ously described [46]. All samples were injected at least
twice to ensure reproducibility.
Calculation of the average acidity constant of apoMTC
and determination of the molar extinction coefficient
for a deprotonated Cys residue
The spectrophotometric titration of apoMT with base is a
common procedure to determine the acidity constants of
the Cys thiol groups, and is based on the characteristic
strong absorption band, between 230 and 240 nm,
assigned to free thiolate ligands [40]. To ensure anaerobic
conditions, sample preparation steps were performed in an
argon-purged glove box. Thus, each point of the titration
of apoMTC with 1 M NaOH was obtained from indi-
vidual 12 lM apoMTC in 10 mM HCl samples that were
kept in sealed 1-cm quartz cuvettes [42]. Twenty-six
spectra between 200 and 400 nm were taken within the
pH range 2–11 and the pH was immediately determined
using a microelectrode. The graphical representation of
the absorbance at 237 nm as a function of the corre-
sponding pH value shows a one-step titration curve and,
thus, the pH of the inflection point can be assigned to an
average pKa value of the Cys residues [40]. The first
derivative of the titration curve afforded a pKa value of
8.9 (Fig. S5). The experimental data thus obtained were
also analyzed by importing both the absorbance and the
pH values into the pHab2000 computer program [47],
which calculates acidity constants by means of a linear
least-squares curve-fitting analysis. The best fit was
obtained for an average apparent pKa value of
9.05 ± 0.01 for all Cys residues, which is consistent with
literature data for other MTs [40, 42].
From the same data, the molar extinction coefficient
per Cys thiolate group can be estimated by dividing the
maximum molar extinction coefficient at 237 nm by the total
number of Cys residues, i.e., [ethiolate (pH 11.0) - ethiolate (pH 2.0)]
/21 = (1.1 9 105)/21 was approximately 5 9 103 M-1 cm-1.
This value was used in the determination of the number of
free Cys residues in holoMTC species as indicated later.
Chelex 100 treatment
Solutions of the reconstituted Zn6–8–MTC and Cd8–MTC
forms were incubated overnight with Chelex 100 resin as
already described [20]. During this time, the sample was
constantly shaken and kept in an argon-purged glove box.
Aliquots of the supernatant solution were analyzed by
means of UV absorption, CD, and ESI-MS measurements.
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Determination of unbound Cys residues in holoMTC
species
Zn6–MTC and Cd7–MTC obtained from the reconstituted
Zn6–8–MTC and Cd8–MTC forms, respectively, after Che-
lex 100 treatment were titrated with NaOH up to pH higher
than 11 and the absorption spectra at the different pH values
were recorded from 400 to 200 nm [42]. The average free
Cys content was calculated from the increase in the molar
extinction coefficient at 237 nm of Zn6–MTC or Cd7–MTC,
from neutral pH up to 11. This increment, De237 =
104 M-1 cm-1 for Zn6–MTC and 3 9 10
3 M-1 cm-1 for
Cd7–MTC, divided by the already determined average
molar extinction coefficient of the Cys thiolate in MTC,
5 9 103 M-1 cm-1 per Cys, was indicative of two free Cys
residues in Zn6–MTC and at most one in Cd7–MTC.
Determination of the apparent binding constant
of Cd(II) bound to MTC
The apparent binding constant of Cd8–MTC at pH 7.0 was
determined as previously described [38] by using an adap-
ted expression of Wang et al. [42]. Briefly, the release of
Cd(II) from Cd8–MTC is achieved by lowering the pH by
the addition of increasing amounts of oxygen-free 1.0 M
HCl. Prior to measurements, a stock solution of Cd8–MTC
was diluted to a final concentration of 5 lM in 10 mM Tris–
HCl, 20 mM NaCl, pH 8.8, and rendered oxygen-free by
three freeze–pump–thaw cycles on a vacuum line. The pH
titration was performed on independent samples prepared in
an argon-purged glove box. Metal release was followed by
recording absorption spectra between 400 and 200 nm of a
sample in a sealed 1-cm cuvette. The pH was determined
using a microelectrode immediately after the spectra had
been recorded. The degree of Cd(II) release is illustrated by
plotting the pH values against the percentage of metal dis-
sociation calculated by D = (e250,i - e250,pH 2.2)/(e250,pH 8.8
- e250,pH 2.2), where e250,i is the molar extinction coefficient
at 250 nm of the Cd(II)–thiolate complex at each pH value
(i) and e250,pH 8.8 and e250,pH 2.2 correspond to Cd8–MTC
(pH 8.8) and apoMTC (pH 2.2), respectively (Fig. S2). The
pH titration profile of Cd8–MTC, as described for Cd7-MT-
3 [41], did not display a pronounced two-step titration
profile. Therefore, only the overall apparent binding
constant was calculated using the following equation:
Kapp,pH 7 = [H
?]n/[Cd2?] 9 10-7n, where [H?] = 10-3.3
and [Cd2?] = 1.92 9 10-5 M denote the proton and Cd(II)
concentrations at the titration midpoint value, respectively
(Fig. S2). On the basis of the CysS-to-Cd(II) stoichiometry
(21:8) the average number of thiolate ligands bound to
Cd(II), n, was considered to be 2.6. From this equation, the
Kapp,pH 7 value of 2.2 9 10
14 M-1 was obtained.
Metal ion binding reactions
The sequential addition of Cu(I) to a solution of either
Zn6–8–MTC at pH 7 or Zn6–8–MTC at pH 3 was monitored
by UV and CD measurements. All manipulations were
carried out in an argon atmosphere at room temperature
and the pH was kept constant throughout the titration. The
procedures followed in the preparation of concentrated
[Cu(MeCN)4]ClO4 stock solution as well as for the UV and
CD monitoring of the previously described titrations have
already been described [20, 48]. In the various titrations,
the initial protein concentration ranged between 10 and
20 lM.
In the titration of apoMTC with Cu(I) a different pro-
cedure was followed to ensure strict anaerobic conditions.
In this case, each point of the titration was obtained using
independent samples. ApoMTC (9 lM) in 0.1 M HCl ali-
quots was titrated with increasing Cu(I) mole equivalents
(0–18) in an argon-purged glove box followed by adjust-
ment of the pH of the sample to 7.2 with 1 M Tris base.
Subsequently, the ESI-MS spectrum of each aliquot was
recorded.
Similarly to the titration with Cu(I), cadmium-binding
studies were carried out using independent samples of
apoMTC (9 lM) in 0.1 M HCl to which increasing
CdCl2 mole equivalents (0–10) were added in an argon-
purged glove box. After each addition, the pH of the
sample was adjusted to 7.2 with 1 M Tris. The CD and UV
spectra were recorded in a sealed cuvette. Immediately
afterward, the ESI-MS spectrum of the same sample was
also recorded.
NMR studies
Reconstitution of apoMTC with 113CdCl2, obtained by
treatment of 113CdO (TRACER Tecnologı´as Analı´ticas)
with a stoichiometric amount of HCl, yielded 113Cd8–MTC.
On the basis of ESI-MS data, further treatment with Chelex
100 resin afforded 113Cd7–MTC. Among the different
attempts to obtain concentrated solutions, lyophilisation
proved to be the most successful. The NMR measurements
were performed at pH 6.5, using a 1 mM solution of the
protein in 90% H2O/10% D2O with 10 mM perdeuterated
Tris–HCl and 0.02% (w/v) sodium azide. To avoid protein
oxidation, the reducing agent b-MeSH was also present at
either low (0.5–1 mM) or high (10–30 mM) concentration.
1H homonuclear NMR experiments were acquired using
Bruker Avance 600 and Bruker Avance 800 spectrometers
operating at 11.74 and 18.78 T, respectively. The former
was equipped with a triple-resonance TXI probe, whereas
the latter had a triple-resonance TCI cryoprobe. The 1H
homonuclear experiments were of the standard form and
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were performed as previously described [49]. Three differ-
ent mixing times (80, 200, and 400 ms) were used at dif-
ferent temperatures (5, 15, and 27 C) in the nuclear
Overhauser enhancement spectroscopy experiments. The
MLEV-17 spin-lock applied for 70 or 160 ms was employed
in the total correlation spectroscopy experiments.
Both the 113Cd direct detection and the heteronuclear
1H–113Cd HMQC experiments were acquired using Bruker
Avance 400 (operating at 9.4 T) and Bruker Avance 600
(11.74 T) spectrometers. The 1H and 113Cd resonance
frequencies were 400.13 (600.13) and 88.97 (133.19) MHz,
respectively. BBO probes were used in 113Cd direct
detections, whereas heteronuclear experiments were car-
ried out with BBO probes (at 11.74 T) or BBI probes
(9.4 T). Spectral windows of 400 ppm, 32,768 acquisition
points, 1H decoupling with the WALTZ-16 pulse sequence,
and recycle times of 1 s were typically used for 113Cd
direct acquisition experiments. A total number of (1.2–
1.5) 9 105 scans, in blocks of 4,096 scans each, were
acquired (i.e. approximately 1.5 days per 1D experiment).
For heteronuclear experiments (1H–113Cd HMQC), spectral
windows of 10 and 150 ppm acquired with 2,048 and 200
complexes data points in the direct (1H) and evolution
(113Cd) dimensions were used. 113Cd decoupling was
achieved with the gap sequence. Solvent signal was elim-
inated by the WATERGATE sequence. Five hundred and
twelve scans per increment were taken. The total duration
of each experiment was approximately 1 day. 113Cd
chemical shifts were referenced with respect to the signal
of a 0.1 M sample of Cd(ClO4)2. The free-induction decays
obtained were multiplied by a squared sine function (p/3-
shifted in the direct dimension and without shifting in the
113Cd evolution). The final 2D spectra consisted of
2,048 9 256 data points. All spectra were processed with
the standard Bruker software (Topspin program) and ana-
lyzed with the program Sparky [50].
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